Renal Cancer - Results from #2480

Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma. September 28, 2020

Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial. September 28, 2020

USP22 promotes proliferation in renal cell carcinoma by stabilizing survivin. September 28, 2020

Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. September 25, 2020

Poststreptococcal acute glomerulonephritis in a girl with renal cell carcinoma: possible pathophysiological association. September 25, 2020

Association of Surgical Delay and Overall Survival in Patients with T2 Renal Masses: Implications for Critical Clinical Decision-Making during the COVID-19 Pandemic. September 25, 2020

Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy. September 24, 2020

A Systematic Review and Meta-Analysis of the Significance of Body Mass Index on Kidney Cancer Outcomes. September 24, 2020

Surgical Outcome of Renal Cell Carcinoma with Tumor Thrombus Extension into Inferior Vena Cava and Right Atrium (Beating Heart Removal of Level 4 Thrombus): A Challenging Scenario. September 24, 2020

Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration. September 23, 2020

Black race may be associated with worse overall survival in renal cell carcinoma patients. September 23, 2020

Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma. September 23, 2020

Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. September 22, 2020

Novel Therapeutic Approaches and the Evolution of Drug Development in Advanced Kidney Cancer. September 22, 2020

Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner. September 22, 2020

The Role of Targeted Therapy in the Management of High-Risk Resected Kidney Cancer: What Have We Learned and How Will It Inform Future Adjuvant Trials. September 21, 2020

Immune Related Adverse Events: Classification and Management Approaches in Advanced Kidney Cancer. September 21, 2020

Biopsy Cell Cycle Proliferation Score Predicts Adverse Surgical Pathology in Localized Renal Cell Carcinoma. September 21, 2020

A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma. September 18, 2020

Validation of a Web-Based Planning Tool for Percutaneous Cryoablation of Renal Tumors. September 18, 2020

Page 125 of 456